Acacia Subsidiary Acquires Vascular Device Technology Patents
Acacia Research Corporation (NASDAQ: ACTG) announced today that a
subsidiary has acquired patents relating to vascular device technology.
“Acacia and its subsidiaries continue to increase the number of patent
portfolios they control in the medical device and diagnostics sectors,”
commented Paul Ryan, CEO.